Vladimir Misik

Editorial

Harish Dureja

Parveen Kumar, Swagat Tripathy and Harish Dureja

Malika Arora and Ashish Baldi

×

Comparative Account of Quality Management and Regulatory Aspects of Products with Health Claims: Existing Approaches and Future Challenges for Probiotics and Herbal Products

Close

Dimple Chaudhary, Swagat Tripathy and Harish Dureja

×

Drug and Cosmetic Amendment Bill in India: A Promising Hope for Healthy Medical Device Regulatory Environment

Close

Shivaji Rai, Apeksha Gupta and Vikas Punetha

Swagat Tripathy, Vandana Prajapati and VijayaKumar Sengodan Guruswamy

×

Product Life Cycle Management for Pharmaceutical Innovation

Close

Prerna Kaushik, Swagat Tripathy, Rishi Sharma and Harish Dureja

×

Anti-Monopoly and Competition Laws - Impact on the Indian Pharmaceutical Industry

Close

Ajmer S. Grewal, Viney Lather, Shashikant Bhardwaj and Deepti Pandita

×

Regulatory Overview of Biosimilars: Current Scenario and Future Opportunities

Close

Malika Arora and Ashish Baldi

×

Good Manufacturing Practice Regulations for Probiotic Based Pharmaceuticals: Current Scenario and Suggestive Recommendations

Close

Leticia Delgado-Herrera, Natalie Boone, Judy Kannenberg, Marcel van Gelderen, Keiichirou Ogawa, Mary Beth Blauwet, Marlowe J Schneidkraut, Sabine Agena, Raymond van Aarle, Yosuke Kubota, Marjan van der Werf-Pieters, Ivanka Baaij and Salim Mujais

×

Enhanced Globalization and Speed to Market for Innovative Medicines

Close